Table of Contents

2019-2024 Global Healthcare-Acquired Infection Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Healthcare-Acquired Infection Market Size 2014-2024
  • 2.1.2 Healthcare-Acquired Infection Market Size CAGR by Region
• 2.2 Healthcare-Acquired Infection Segment by Type
  • 2.2.1 Pharmaceutical Treatment
  • 2.2.2 Environment Treatment
  • 2.2.3 Medical Devices Management
• 2.3 Healthcare-Acquired Infection Market Size by Type
  • 2.3.1 Global Healthcare-Acquired Infection Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Healthcare-Acquired Infection Market Size Growth Rate by Type (2014-2019)
• 2.4 Healthcare-Acquired Infection Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Clinics
  • 2.4.3 Ambulatory Surgery Centers
  • 2.4.4 Others
• 2.5 Healthcare-Acquired Infection Market Size by Application
  • 2.5.1 Global Healthcare-Acquired Infection Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Healthcare-Acquired Infection Market Size Growth Rate by Application (2014-2019)

3 Global Healthcare-Acquired Infection by Players

• 3.1 Global Healthcare-Acquired Infection Market Size Market Share by Players
  • 3.1.1 Global Healthcare-Acquired Infection Market Size by Players (2017-2019)
  • 3.1.2 Global Healthcare-Acquired Infection Market Size Market Share by Players (2017-2019)
• 3.2 Global Healthcare-Acquired Infection Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Healthcare-Acquired Infection by Regions

• 4.1 Healthcare-Acquired Infection Market Size by Regions
• 4.2 Americas Healthcare-Acquired Infection Market Size Growth
• 4.3 APAC Healthcare-Acquired Infection Market Size Growth
• 4.4 Europe Healthcare-Acquired Infection Market Size Growth
• 4.5 Middle East & Africa Healthcare-Acquired Infection Market Size Growth

5 Americas

• 5.1 Americas Healthcare-Acquired Infection Market Size by Countries
• 5.2 Americas Healthcare-Acquired Infection Market Size by Type
• 5.3 Americas Healthcare-Acquired Infection Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Healthcare-Acquired Infection Market Size by Countries
• 6.2 APAC Healthcare-Acquired Infection Market Size by Type
• 6.3 APAC Healthcare-Acquired Infection Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Healthcare-Acquired Infection by Countries
• 7.2 Europe Healthcare-Acquired Infection Market Size by Type
• 7.3 Europe Healthcare-Acquired Infection Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Healthcare-Acquired Infection by Countries
• 8.2 Middle East & Africa Healthcare-Acquired Infection Market Size by Type
• 8.3 Middle East & Africa Healthcare-Acquired Infection Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Healthcare-Acquired Infection Market Forecast

• 10.1 Global Healthcare-Acquired Infection Market Size Forecast (2019-2024)
• 10.2 Global Healthcare-Acquired Infection Forecast by Regions
  • 10.2.1 Global Healthcare-Acquired Infection Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Healthcare-Acquired Infection Forecast by Type
• 10.8 Global Healthcare-Acquired Infection Forecast by Application

11 Key Players Analysis

• 11.1 Pfizer
  • 11.1.1 Company Details
  • 11.1.2 Healthcare-Acquired Infection Product Offered
  • 11.1.3 Pfizer Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Pfizer News
• 11.2 Novartis
  • 11.2.1 Company Details
  • 11.2.2 Healthcare-Acquired Infection Product Offered
  • 11.2.3 Novartis Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Novartis News
• 11.3 Roche
  • 11.3.1 Company Details
  • 11.3.2 Healthcare-Acquired Infection Product Offered
  • 11.3.3 Roche Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Roche News
• 11.4 Sanofi
  • 11.4.1 Company Details
  • 11.4.2 Healthcare-Acquired Infection Product Offered
  • 11.4.3 Sanofi Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Sanofi News
• 11.5 Abbott
  • 11.5.1 Company Details
  • 11.5.2 Healthcare-Acquired Infection Product Offered
  • 11.5.3 Abbott Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Abbott News
• 11.6 BD
  • 11.6.1 Company Details
  • 11.6.2 Healthcare-Acquired Infection Product Offered
  • 11.6.3 BD Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 BD News
• 11.7 Hologic
  • 11.7.1 Company Details
  • 11.7.2 Healthcare-Acquired Infection Product Offered
  • 11.7.3 Hologic Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2017-2019)
  • 11.7.4 Main Business Overview
  • 11.7.5 Hologic News

...

12 Research Findings and Conclusion

The healthcare-acquired infection is a new infection that develops in a patient during hospitalization.

According to this study, over the next five years the Healthcare-Acquired Infection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Healthcare-Acquired Infection business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Healthcare-Acquired Infection market by product type, application, key companies and key regions.

This study considers the Healthcare-Acquired Infection value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Pharmaceutical Treatment
Environment Treatment
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Clinics
Ambulatory Surgery Centers
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Novartis
Roche
Sanofi
Abbott
BD
Hologic
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Healthcare-Acquired Infection market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Healthcare-Acquired Infection market by identifying its various subsegments.
Focuses on the key global Healthcare-Acquired Infection players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Healthcare-Acquired Infection with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Healthcare-Acquired Infection submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.